Company Overview
Puma Biotechnology (PBYI) is a pharmaceutical company producing drugs used in cancer treatments. Their main product is Nerylinx, a compound used to treat breast cancer, specifically those that are HER-2 positive.
The company has seen much volatility in terms of earnings and price. Having reached peaks of almost $250/sh the company now trades at a mere $10 per share. Most recently, the company produced disappointing results, with sales of their main product Nerlynx producing revenues below expectations. Below we can see the latest quarterly results.
As we can see,